Melanoma Cancer Market Trends, Size, Competitive Analysis and Forecast 2021-2026
The global melanoma cancer market is anticipated to grow at a CAGR of around 12.3% during the forecast period (2021-2027). The factor propelling the growth of the market include the rise in the number of FDA approvals for melanoma cancer drugs/systems produced by key market players. For instance, in July 2021, Genentech, a subsidiary of F. Hoffmann-La Roche Ltd, got the approval for Tecentriq (atezolizumab) plus Cotellic (cobimetinib) and Zelboraf (vemurafenib). These drugs are used for the treatment of BRAF V600 mutation-positive advanced melanoma. The FDA approval is supported by results from the Phase 3 IMspire150 clinical trial done on peoples who suffered from advanced melanoma and previously untreated BRAF V600 mutation. The approval will support Roche to build a strong market for the Tecentriq/Cotellic combo.
To Request a Sample of our Report on Melanoma Cancer Market: https://www.omrglobal.com/request-sample/melanoma-cancer-market
Moreover, in May 2020,
SciBase, announced that it has received approval from the FDA for Nevisense
3.0, the third generation of their Nevisense system for early melanoma
detection. Nevisence is an AI-based point-of-care system that is used for the
non-invasive evaluation of irregular moles. Through this approval for the
system to detect early melanoma cancer will support the company to expand its
marketing and sales activities in the market. Thus, these approvals by FDA will
impact positively the growth of the melanoma cancer market during the forecast
period.
A full Report of Melanoma
Cancer Market is Available at: https://www.omrglobal.com/industry-reports/melanoma-cancer-market
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Diagnosis
·
By Therapy
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
·
Competitive Landscape- Bristol-Myers Squibb Co.,
GlaxoSmithKline plc, AstraZeneca PLC, Amgen Inc, Novartis AG, Abbott
Laboratories, Johnson & Johnson Services, Inc., and others.
Global
Melanoma Cancer Market Segmentation
·
Biopsy
·
Computed
Tomography (CAT) Scan
·
Magnetic
Resonance Imaging (MRI)
·
Positron
Emission Tomography (PET) Scan
By Therapy
·
Chemotherapy
·
Immunotherapy
·
Targeted
Therapy
·
Radiation
Therapy
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
China
·
India
·
Japan
·
South
Korea
·
Rest of
Asia-Pacific
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
Abbott
Laboratories
·
Ab
Sciences
·
AbbVie
Inc.
·
Amgen,
Inc.
·
AstraZeneca
plc
·
Bristol-Myers
Squibb Co.
·
Castle
Biosciences, Inc.
·
Celgene
Corp.
·
Chinook
Therapeutics, Inc.
·
Daiichi
Sankyo Co., Ltd.
·
ENB
Therapeutics
·
Eisai
Co Ltd.
·
F.
Hoffman-La Roche Ltd.
·
GlaxoSmithKline
PLC
·
Incyte
Corp.
·
Iovance
Biotherapeutics Inc.
·
Johnson
& Johnson Services, Inc.
·
Merck
& Co., Inc.
·
Novartis
AG
·
Pierre
Fabre S. A.
·
SciBase
AB
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/melanoma-cancer-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports, consulting
and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment